Yuting Sang

2.2k citations

20 papers · 1.5k · 1 hit paper · h-index 12

Impact in

Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 10%
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- RNA Research and Splicing

Papers in

Cancer Research 14
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 5
- Breast Cancer Treatment Studies 4
Molecular Biology 13
- Circular RNAs in diseases 11
- RNA modifications and cancer 4
- Extracellular vesicles in disease 2
- RNA Research and Splicing 1

Co-authors: Qifeng Yang (12 shared papers)Yiran Liang (11 shared papers)Ying Liu (10 shared papers)Hanwen Zhang (10 shared papers)Yaming Li (10 shared papers)Ning Zhang (9 shared papers)Xiaojin Song (10 shared papers)Wenjing Zhao (9 shared papers)
Journals: Oncogene (2 papers)Cancer Research (2 papers)Cell Death and Disease (2 papers)Molecular Therapy — Nucleic Acids (2 papers)Frontiers in Genetics (1 paper)
Partner nations: China United States Canada

In The Last Decade

Yuting Sang

20 papers receiving 1.5k citations

Yuting Sang's Hit Papers

align trajectories log scale

circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer 2019 · 345 citations

Peers

Countries citing papers authored by Yuting Sang

Since Specialization

Citations

This map shows the geographic impact of Yuting Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Sang more than expected).

Fields of papers citing papers by Yuting Sang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuting Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Sang. The network helps show where Yuting Sang may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuting Sang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuting Sang Line = papers co-authored together Yuting Sang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer Molecular Therapy ·Yuting Sang, Bing Chen, Xiaojin Song, Yaming Li, Yiran Liang, Dianwen Han, Ning Zhang, Hanwen Zhang, Ying Liu, Tong Chen, Chen Li, Lijuan Wang, Wenjing Zhao, Qifeng Yang Hit paper breakdown →	2019	345
2	LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215 Journal of Cellular Physiology ·Xiaoli Kong, Yi Duan, Yuting Sang, Yaming Li, Hanwen Zhang, Yiran Liang, Ying Liu, Ning Zhang, Qifeng Yang	2018	239
3	Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28 Theranostics ·Bing Chen, Yuting Sang, Xiaojin Song, Dong Zhang, Lijuan Wang, Wenjing Zhao, Yiran Liang, Ning Zhang, Qifeng Yang	2021	184
4	MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1 Cell Death and Disease ·Yaming Li, Yiran Liang, Yuting Sang, Xiaojin Song, Hanwen Zhang, Ying Liu, Liyu Jiang, Qifeng Yang	2018	149
5	circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer Oncogene ·Yiran Liang, Xiaojin Song, Yaming Li, Peng Su, Dianwen Han, Tingting Ma, Renbo Guo, Bing Chen, Wenjing Zhao, Yuting Sang, Ning Zhang, Xiaoyan Li, Hanwen Zhang, Ying Liu, Yi Duan, Lijuan Wang, Qifeng Yang	2019	114
6	Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer Cancer Research ·Hanwen Zhang, Ning Zhang, Ying Liu, Peng Su, Yiran Liang, Yaming Li, Xiaolong Wang, Tong Chen, Xiaojin Song, Yuting Sang, Yi Duan, Jiashu Zhang, Lijuan Wang, Bing Chen, Wenjing Zhao, Haiyang Guo, Zhaojian Liu, Guohong Hu, Qifeng Yang	2019	109
7	Targeting the circBMPR2/miR-553/USP4 Axis as a Potent Therapeutic Approach for Breast Cancer Molecular Therapy — Nucleic Acids ·Yiran Liang, Xiaojin Song, Yaming Li, Tingting Ma, Peng Su, Renbo Guo, Bing Chen, Hanwen Zhang, Yuting Sang, Ying Liu, Yi Duan, Ning Zhang, Xiaoyan Li, Wenjing Zhao, Lijuan Wang, Qifeng Yang	2019	68
8	Enhancing robustness of monthly streamflow forecasting model using gated recurrent unit based on improved grey wolf optimizer Journal of Hydrology ·Xuehua Zhao, Hanfang Lv, Lv Shujin, Yuting Sang, Yizhao Wei, Xueping Zhu	2021	65
9	A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer Cell Death and Disease ·Yiran Liang, Xiaojin Song, Yaming Li, Yuting Sang, Ning Zhang, Hanwen Zhang, Ying Liu, Yi Duan, Bing Chen, Renbo Guo, Wenjing Zhao, Lijuan Wang, Qifeng Yang	2018	59
10	Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer Cancer Biology & Therapy ·Yiran Liang, Yaming Li, Xiaojin Song, Ning Zhang, Yuting Sang, Hanwen Zhang, Ying Liu, Bing Chen, Wenjing Zhao, Lijuan Wang, Renbo Guo, Zhigang Yu, Qifeng Yang	2018	59
11	circHMCU Promotes Proliferation and Metastasis of Breast Cancer by Sponging the let-7 Family Molecular Therapy — Nucleic Acids ·Xiaojin Song, Yiran Liang, Yuting Sang, Yaming Li, Hanwen Zhang, Bing Chen, Lutao Du, Ying Liu, Lijuan Wang, Wenjing Zhao, Tingting Ma, Chuanxin Wang, Qifeng Yang	2020	50
12	Plasma extracellular vesicle long RNA profiles in the diagnosis and prediction of treatment response for breast cancer npj Breast Cancer ·Yonghui Su, Yuchen Li, Rong Guo, Jingjing Zhao, Weiru Chi, Hongyan Lai, Jia Wang, Zhen Wang, Lun Li, Yuting Sang, Jianjing Hou, Jingyan Xue, Zhimin Shao, Yayun Chi, Shenglin Huang, Jiong Wu	2021	34
13	Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective study Frontiers in Oncology ·Yuting Sang, Xujie Zhou, Weiru Chi, Jiajian Chen, Benlong Yang, Shuang Hao, Xiaoyan Huang, Guangyu Liu, Zhimin Shao, Jiong Wu	2022	8
14	Identification of gene mutations in six Chinese patients with maple syrup urine disease Frontiers in Genetics ·Lulu Li, Xinmei Mao, Nan Yang, Taoyun Ji, Shunan Wang, Yulan Ma, Haihe Yang, Yuting Sang, Jinqi Zhao, Lifei Gong, Yue Tang, Yuanyuan Kong	2023	6
15	Langer's axillary arch lymph node metastasis in breast cancer patients: A prospective clinical study Surgical Oncology ·Yuting Sang, Xiaoli Kong, Xiaoyan Li, Liyu Jiang, Tingting Ma, Wenjing Zhao, Qifeng Yang	2019	6
16	Treatment and survival outcomes in older women with primary breast cancer: A retrospective propensity score-matched analysis The Breast ·Yuting Sang, Benlong Yang, Miao Mo, Shiyang Liu, Xujie Zhou, Jiajian Chen, Shuang Hao, Xiaoyan Huang, Guangyu Liu, Zhimin Shao, Jiong Wu	2022	4
17	MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast Cancer International Journal of Molecular Sciences ·Weiru Chi, Bingqiu Xiu, Min Xiong, Xuliren Wang, Pei Li, Qi Zhang, Jianjing Hou, Yuting Sang, Xujie Zhou, Ming Chen, Shuyue Zheng, Li-Yi Zhang, Jingyan Xue, Yayun Chi, Jiong Wu	2023	2
18	Correction: circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer Oncogene ·Yiran Liang, Xiaojin Song, Yaming Li, Peng Su, Dianwen Han, Tingting Ma, Renbo Guo, Bing Chen, Wenjing Zhao, Yuting Sang, Ning Zhang, Xiaoyan Li, Hanwen Zhang, Ying Liu, Yi Duan, Lijuan Wang, Qifeng Yang	2021	2
19	Comparison of Time-Varying Pattern of Recurrence in Chinese Breast Cancer Patients with Different Molecular Subtypes: A Single-Center Retrospective Study ONCOLOGIE ·(unknown), Yuting Sang, Jiajian Chen, Miao Mo, Jianjing Hou, Benlong Yang, Jiong Wu	2022	2
20	Abstract P2-14-02: Surgical options of the breast and clinical outcomes in breast cancer patients after neoadjuvant chemotherapy: a single-center retrospective study Cancer Research ·Yuting Sang, Jiajian Chen, Benlong Yang, Shuang Hao, Xiaoyan Huang, Guang‐Yu Liu, Zhimin Shao, Jiong Wu	2023	1

About Yuting Sang

Yuting Sang is a scholar working on Cancer Research, Molecular Biology, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Circular RNAs in diseases (11 papers), MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers), Breast Cancer Treatment Studies (4 papers), RNA modifications and cancer (4 papers), HER2/EGFR in Cancer Research (2 papers), Extracellular vesicles in disease (2 papers) and RNA Research and Splicing (1 paper). The work is most often cited by research in Cancer Research (970 citations), Molecular Biology (1.1k citations), Geriatrics and Gerontology (29 citations), Oncology (110 citations) and Environmental Engineering (54 citations). Yuting Sang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Qifeng Yang, Yiran Liang, Ying Liu, Hanwen Zhang, Yaming Li, Ning Zhang, Xiaojin Song, Wenjing Zhao, Bing Chen and Lijuan Wang. Their work appears in journals such as Oncogene, Cancer Research, Cell Death and Disease, Molecular Therapy — Nucleic Acids and Frontiers in Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Yuting Sang

Impact in

Papers in i

In The Last Decade

Yuting Sang

Yuting Sang's Hit Papers

Peers

Countries citing papers authored by Yuting Sang

Fields of papers citing papers by Yuting Sang

All Works

About Yuting Sang

Explore authors with similar magnitude of impact

Papers in